|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/335 | (2006.01) |
| A61K 9/08 | (2013.01) | ||
| A61K 31/5377 | (2006.01) | ||
| A61K 31/138 | (2013.01) | ||
| A61K 31/335 | (2013.01) | ||
| A61K 9/06 | (2006.01) | ||
| A61K 31/343 | (2013.01) | ||
| A61K 9/08 | (2006.01) | ||
| A61K 31/138 | (2006.01) | ||
| A61K 31/353 | (2013.01) | ||
| A61K 31/343 | (2006.01) | ||
| A61K 31/4704 | (2013.01) | ||
| A61K 31/353 | (2006.01) | ||
| A61K 31/5377 | (2013.01) | ||
| A61K 31/4704 | (2006.01) | ||
| A61P 27/02 | (2018.01) | ||
| A61P 27/02 | (2006.01) | ||
| A61P 27/06 | (2018.01) | ||
| A61P 27/06 | (2006.01) | ||
| A61K 9/0048 | (2013.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61K 47/12 | (2013.01) | ||
| A61K 47/02 | (2006.01) | ||
| A61K 47/26 | (2013.01) | ||
| A61K 47/12 | (2006.01) | ||
| A61K 47/02 | (2013.01) | ||
| A61K 47/26 | (2006.01) | ||
| A61K 9/06 | (2013.01) |
| (11) | Number of the document | 3730137 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18891086.3 |
| Date of filing the European patent application | 2018-12-20 | |
| (97) | Date of publication of the European application | 2020-10-28 |
| (45) | Date of publication and mention of the grant of the patent | 2024-03-20 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/JP2018/047102 |
| Date | 2018-12-20 |
| (87) | Number | WO 2019/124523 |
| Date | 2019-06-27 |
| (30) | Number | Date | Country code |
| 2017244573 | 2017-12-21 | JP |
| (72) |
YAMANE, Shinsaku , JP
NAKAYAMA, Satoshi , JP
NAGAI, Kazufumi , JP
MORIYUKI, Kazumi , JP
KARAKAWA, Tomohiro , JP
|
| (73) |
ONO PHARMACEUTICAL CO., LTD. ,
1-5, Doshomachi 2-chome
Chuo-ku, Osaka-shi, Osaka 541-8526,
JP
|
| (54) | THERAPEUTIC AGENT FOR GLAUCOMA COMPRISING AN FP AGONIST AND TIMOLOL |
| THERAPEUTIC AGENT FOR GLAUCOMA COMPRISING AN FP AGONIST AND TIMOLOL |